A portrait illuminates a metaphor for maldistribution of burden of disease, risk exposure, and long-standing inequity in health laid bare to the world during the COVID-19 pandemic.
AMA J Ethics. 2021;23(3):E283-284. doi:
10.1001/amajethics.2021.283.
This commentary explores legal, ethical, and practical considerations for pharmacists and prescribers working together to address uncertainty in drug prescribing.
AMA J Ethics. 2021;23(6):E471-479. doi:
10.1001/amajethics.2021.471.
Furthering clinicians’ understandings of how daily practice can respond to Black patients' experiences can help restore trust and mitigate racial and ethnic health inequity.
AMA J Ethics. 2021;23(6):E480-486. doi:
10.1001/amajethics.2021.480.
A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices.
AMA J Ethics. 2021;23(9):E712-720. doi:
10.1001/amajethics.2021.712.
Jennifer Erdrich, MD, MPH and Carlos R. Gonzales, MD
Tribal-university partnerships are fewer in education than in research, but just as important for expanding opportunity and improving health infrastructure.
AMA J Ethics. 2020;22(10):E851-855. doi:
10.1001/amajethics.2020.851.
The high prevalence of violence experienced by Native American women and femme-identifying individuals requires clinicians and staff to better understand social determinants of violence.
AMA J Ethics. 2020;22(10):E888-892. doi:
10.1001/amajethics.2020.888.
American visual and narrative representations of Native experiences suggest an obligation to look on 19th-century White American artists’ romanticizations of those experiences with humility.
AMA J Ethics. 2020;22(10):E898-903. doi:
10.1001/amajethics.2020.898.